SK14032000A3 - Derivát kyseliny barbiturovej a prípravok na prevenciu a liečbu ochorení kostí a chrupiek, ktorý ho obsahuje - Google Patents

Derivát kyseliny barbiturovej a prípravok na prevenciu a liečbu ochorení kostí a chrupiek, ktorý ho obsahuje Download PDF

Info

Publication number
SK14032000A3
SK14032000A3 SK1403-2000A SK14032000A SK14032000A3 SK 14032000 A3 SK14032000 A3 SK 14032000A3 SK 14032000 A SK14032000 A SK 14032000A SK 14032000 A3 SK14032000 A3 SK 14032000A3
Authority
SK
Slovakia
Prior art keywords
substituted
group
barbituric acid
groups
compound
Prior art date
Application number
SK1403-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Kunikazu Sakai
Yusuke Satoh
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of SK14032000A3 publication Critical patent/SK14032000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1403-2000A 1998-03-27 1999-03-23 Derivát kyseliny barbiturovej a prípravok na prevenciu a liečbu ochorení kostí a chrupiek, ktorý ho obsahuje SK14032000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10100355A JPH11279157A (ja) 1998-03-27 1998-03-27 バルビツール酸誘導体およびそれらからなる骨・軟骨疾患予防・治療薬
PCT/IB1999/000961 WO1999050252A2 (en) 1998-03-27 1999-03-23 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same

Publications (1)

Publication Number Publication Date
SK14032000A3 true SK14032000A3 (sk) 2001-03-12

Family

ID=14271794

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1403-2000A SK14032000A3 (sk) 1998-03-27 1999-03-23 Derivát kyseliny barbiturovej a prípravok na prevenciu a liečbu ochorení kostí a chrupiek, ktorý ho obsahuje

Country Status (20)

Country Link
US (1) US6498164B1 (ja)
EP (1) EP1064269A1 (ja)
JP (1) JPH11279157A (ja)
KR (1) KR20010042182A (ja)
CN (1) CN1295565A (ja)
AU (1) AU759249B2 (ja)
BR (1) BR9909139A (ja)
CA (1) CA2324584A1 (ja)
CZ (1) CZ20003460A3 (ja)
EA (1) EA200000992A1 (ja)
HU (1) HUP0101505A3 (ja)
IL (1) IL138433A0 (ja)
NO (1) NO20004798L (ja)
NZ (1) NZ506616A (ja)
PL (1) PL343433A1 (ja)
SK (1) SK14032000A3 (ja)
TR (1) TR200002785T2 (ja)
WO (1) WO1999050252A2 (ja)
YU (1) YU57800A (ja)
ZA (1) ZA200004473B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005082079A2 (en) * 2004-02-26 2005-09-09 Inotek Pharmaceuticals Corporation Tetracyclic lactam derivatives and uses thereof
CN102070623B (zh) * 2010-12-20 2012-07-25 新乡医学院 一种巴比妥酸衍生物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921072A (en) * 1956-10-18 1960-01-12 Jr Edgar A Ferguson Nicotinic acid substituents of barbituric acid
GB1339748A (en) * 1970-07-02 1973-12-05 Ici Ltd Pyrimidine derivatives
JPS5829281B2 (ja) * 1974-06-04 1983-06-22 日本曹達株式会社 バルビツ−ル酸系除草剤
US4695673A (en) * 1985-11-20 1987-09-22 Stauffer Chemical Company Process for the production of acylated 1,3-dicarbonyl compounds
US4797147A (en) * 1986-06-09 1989-01-10 Stauffer Chemical Company Herbicidal method and composition utilizing certain 5-(2-substituted benzoyl)-barbituric acids
US4938796A (en) * 1987-07-06 1990-07-03 Ici Americas Inc. Herbicidal compositions of acylated 1,3-dicarbonyl herbicides and antidotes therefor
JP2588779B2 (ja) * 1989-09-18 1997-03-12 富士写真フイルム株式会社 電子写真式製版用印刷原版
US5102760A (en) * 1989-09-18 1992-04-07 Fuji Photo Film Co., Ltd. Electrophotographic photoreceptor and electrophotographic printing plate precursor comprising phthalocyanine pigment and thiobarbituric acid derivative
JP2588780B2 (ja) * 1989-09-26 1997-03-12 富士写真フイルム株式会社 電子写真感光体
JPH03179361A (ja) * 1989-12-07 1991-08-05 Fuji Photo Film Co Ltd 光導電性組成物およびそれを用いた電子写真感光材料
US5141943A (en) * 1990-04-12 1992-08-25 Brown University Research Foundation 5-benzyl barbiturate derivatives
NL9001075A (ja) * 1990-05-04 1991-12-02 Duphar Int Res
DK0517660T3 (da) * 1991-06-05 1997-10-27 Ciba Geigy Ag Benzo-1,2,3-thiadiazol-derivater.
EP0809634A4 (en) * 1995-02-13 1998-05-20 Kirpal S Gulliya NEW USES FOR BARBITURIC ACID ANALOGS
JPH10316608A (ja) * 1997-05-14 1998-12-02 Hoechst Yakuhin Kogyo Kk ポリヒドロキシフェノール誘導体およびそれらからなる骨・軟骨疾患予防・治療剤

Also Published As

Publication number Publication date
HUP0101505A2 (hu) 2002-03-28
YU57800A (sh) 2002-10-18
NO20004798D0 (no) 2000-09-26
BR9909139A (pt) 2000-12-05
EP1064269A1 (en) 2001-01-03
AU3726099A (en) 1999-10-18
NZ506616A (en) 2003-04-29
ZA200004473B (en) 2001-05-30
TR200002785T2 (tr) 2001-02-21
IL138433A0 (en) 2001-10-31
US6498164B1 (en) 2002-12-24
CA2324584A1 (en) 1999-10-07
NO20004798L (no) 2000-11-20
WO1999050252A3 (en) 2000-01-13
AU759249B2 (en) 2003-04-10
WO1999050252A2 (en) 1999-10-07
JPH11279157A (ja) 1999-10-12
PL343433A1 (en) 2001-08-13
KR20010042182A (ko) 2001-05-25
EA200000992A1 (ru) 2001-06-25
CZ20003460A3 (cs) 2001-08-15
HUP0101505A3 (en) 2002-06-28
CN1295565A (zh) 2001-05-16

Similar Documents

Publication Publication Date Title
US5606058A (en) Compounds for the treatment of pneumocystis carinii Pneumonia, Giardia Lamblia, and Cryptospordium parnum
SE457081B (sv) 1,2-diaminocyklobutan-3,4-dioner, foerfarande foer framstaellning av dessa, mellanprodukt och en farmaceutisk komposition
JP2972377B2 (ja) カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物
JPS5995269A (ja) 抗てんかん性医薬品
US4560686A (en) Method for treating circulatory diseases by using (2-lower alkoxyphenyl)piperazine derivatives
US5236942A (en) 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful in the treatment of Altzheimer's dementia
EP0452926B1 (en) 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful as memory enhancers
JPS6013767A (ja) ピリミジン誘導体
SK14032000A3 (sk) Derivát kyseliny barbiturovej a prípravok na prevenciu a liečbu ochorení kostí a chrupiek, ktorý ho obsahuje
CS274441B2 (en) Method of 1-acyl-3-/4-(2-pyrimidinyl)-1-piperazinyl/propanes production
CS219885B2 (en) Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide
US5331002A (en) 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful as memory enhancers
CS227012B2 (en) Method of preparing 2-amino-3-benzoyl-phenylacetamide
EP0278499A2 (en) 9-Amino-1,4-ethano-1,2,3,4-tetrahydroacridine and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
DE3438585A1 (de) Neue sulfoxide, verfahren zu ihrer herstellung und ihre verwendung
SK152095A3 (en) Crystalline (+) l-hydrogentartrate, preparation method thereof, pharmaceutical composition containing its and its use
MXPA00009358A (en) Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
KR20080014017A (ko) (5z)-5-(6-퀴녹살리닐메틸리덴)-2-[(2,6-디클로로페닐)아미노]-1,3-티아졸-4(5h)-온
JPS5976083A (ja) ジヒドロピリジン類
CZ337295A3 (en) Naphthyridine derivatives, process of their preparation and pharmaceutical compositions containing thereof
KR100556559B1 (ko) 2-(4-(4-(4,5-디클로로-2-메틸이미다졸-1-일)부틸)-1-피페라지닐)-5-플루오로피리미딘, 이것의 제조 방법 및 이것의치료적 용도
CS228531B2 (en) Method for the production of phenylpiperazine derivates
KR890004197B1 (ko) 티아디아졸 항비루스제
EP0573391A1 (de) Thiosemicarbazonsäureester und ihre Anwendung als Arzneimittelwirkstoff
JPH01113398A (ja) 光学活性なジヒドロピリジン−5−ホスホン酸エステル